Selenium Supplementation in Pregnant Women with Autoimmune Thyroiditis: A Practical Approach

Nutrients. 2022 May 27;14(11):2234. doi: 10.3390/nu14112234.

Abstract

Selenium (Se) is an essential trace element with antioxidant and anti-inflammatory properties and a pivotal role in thyroid metabolism. Ensuring a sufficient Se supply is possible via a balanced, wholesome diet; however, Se content in foods may be different throughout geographical areas. Se supplementation is expected to improve inflammatory status in patients with autoimmune thyroiditis, especially in those with high activity, and has been demonstrated as effective in reducing the thyroid peroxidase antibodies titer. Se status seems to affect thyroid function in pregnancy, which prompts the potential role of Se supplementation in such patients. Few clinical trials have investigated the effectiveness of Se supplementation in pregnant women with thyroiditis, and their results suggest the safety and effectiveness of this element in reducing autoantibody levels and preventing postpartum thyroiditis development, although limited. Hence, more robust evidence is needed to confirm these data. The current study aims to summarize published data on the relationship between Se and thyroid status in pregnant women with thyroiditis and the potential use of Se. Moreover, an algorithm for Se supplementation is proposed for pregnant women with thyroiditis to help endocrinologists in daily clinical practice to consider Se status.

Keywords: autoimmune thyroiditis; pregnancy; selenium; thyroid.

Publication types

  • Review

MeSH terms

  • Dietary Supplements
  • Female
  • Hashimoto Disease* / drug therapy
  • Humans
  • Pregnancy
  • Pregnant Women
  • Selenium* / therapeutic use
  • Thyroiditis, Autoimmune* / drug therapy

Substances

  • Selenium

Grants and funding

This research received no external funding.